SEC Form 4 · accession 0001645627-17-000064
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 16, 2017
Accepted (ET)
May 18, 2017 · 11:38 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 16, 2017 | P | 1,000 | $0.0611 | A | 20,817,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0611 | A | 20,818,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0616 | A | 20,819,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0632 | A | 20,820,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0632 | A | 20,821,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.06 | A | 20,822,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.06 | A | 20,823,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.06 | A | 20,824,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.06 | A | 20,825,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0635 | A | 20,826,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0636 | A | 20,827,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0633 | A | 20,828,949 | D |
Table II — derivative securities
No Table II lines on this filing.